Effect of Intravenous Amantadine on Gait Freezing in Parkinson's Disease

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2011
A double-blinded randomized placebo-controlled trial of intravenous amantadine on gait freezing refractory to oral anti-parkinsonian medications in patients with Parkinson\'s disease. * administration of IV amantadine or normal saline for 5 days, 2 times a day while keeping current oral anti-parkinsonian medications unchanged * follow-up after administration of IV amantadine for 4 weeks * allocation ratio of amantadine:normal saline is 2:1
Epistemonikos ID: bad655af81f903350f56549be75fd08830480d5c
First added on: May 06, 2024